Chris joined Gentronix in 2013 and is the Senior Study Director within the business. Chris has 45 years’ experience in Genetic Toxicology having previously worked for leading global pharmaceutical and R&D companies. Initially joining Gentronix to introduce the Bacterial Reverse Mutation Assay (Ames test) and implementation of GLP compliance in the organisation; Chris now provides expert training, guidance and mentoring to Study Directors within the company as well as leading the Ames testing activities.
Current role